To our knowledge, previous studies have rarely analyzed the clinical importance of serum levels of IL-6, IL-8, and TNF-α altogether in patients with ovarian carcinoma and ovarian benign cystic lesions. This evidence concerns the gene CXCL8 and ovarian carcinoma.